Sovleplenib in patients with primary or secondary warm autoimmune haemolytic anaemia: results from phase 2 of a randomised, double-blind, placebo-controlled, phase 2/3 study

https://www.thelancet.com/journals/lanhae/article/PIIS2352-3026(24)00344-2/abstract?utm_campaign=update-lanhae&utm_medium=email&dgcid=hubspot_update_feature_updatealerts_lanhae&_hsenc=p2ANqtz-_hypdapzUJ4InOKVRMeUwKzB-QqqEVoAmwYmju1IlPam5w5-w61OhlbxynRGNeTnz72nJ7o3AtlaI8vZdD8yocAIhQHw&_hsmi=347567205&utm_content=347192147&utm_source=hs_email